S&P 5007,659▼ 1.09%Nasdaq26,140▼ 2.15%Dow Jones52,002▼ 0.34%Nasdaq 10029,188▼ 2.50%VIX19.99▲ 21.45%US Dollar101.84▼ 0.21%Gold (GLD)382.01▼ 0.18%Oil (USO)161.76▲ 2.83%
Home › EL › Research report
← EL page
XStocksXray
Research report · 16 October 2026

Estee Lauder Companies Inc (EL)

Consumer Staples · Personal Care Products · US stock · price as of 16 Oct 2026

Key indicators

Price$104.54
52-week range$65.74 – $120.38
Market cap$38.1B
P/E (trailing)209.4×
EV / EBITDA26.6×
Free-cash-flow yield3.5%
Dividend yield1.3%
Revenue (last 12 months)$15.0B
Revenue growth (3y a year)−1.8%
Operating margin5.2%
Return on invested capital5.7%
Net debt / EBITDA3.6×

Fair value

Blended fair value$27.34 range $21 – $27
Versus priceOvervalued−74% to fair value
Peer multiples$28.78
Fundamentals-adjusted multiple$25.90
10-year DCF (market-scaled)$3.96
Earnings power value (floor, not blended)$8.22
Model uncertaintyMedium

X-Ray Score

33/ 100 · High confidence · ahead of 3% of sector peers
Valuation11
Growth40
Profitability47
Financial health38
Dividends27

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

1.7992.41183274364Fair value $272021-102023-012024-042025-072026-10

Executive summary

Prestige beauty is the focus of Estee Lauder Companies, which makes and markets products in skin care, makeup, fragrance and hair care. Its brands include Estee Lauder, Clinique, MAC, La Mer, Aveda and Jo Malone London. Products reach consumers through department stores, specialty beauty shops, travel retail locations, the company's own stores and websites. The business is managed by product category and by geographic region, with the Americas, Europe and Asia as the main areas.

Revenue of $15.0 billion over the last twelve months comes from supplying premium beauty products through retail partners and the company's own channels. Revenue has changed at -1.8% a year across the last three years. The operating margin is 5.2%, the business earns 6% on the capital invested in it, and net debt is 3.6 times EBITDA. The dividend yield is 1.3%.

StocksXray gives Estee Lauder Companies Inc an X-Ray Score of 33 out of 100 (high confidence), ahead of 3% of the S&P 500 stocks in its sector. Its strongest lens is profitability (47) and its weakest is valuation (11).

Our fair value blend is $27.34 (range $21.21 to $27.34). At $104.54 the stock trades 282% above that blend, so the label is "Overvalued" with medium model uncertainty. Fair value is a range, not a price target.

stocksxray.com · page 1
XStocksXray
Estee Lauder Companies Inc (EL)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

FY2022FY2023FY2024FY2025FY2026Now
Price$237.26$185.08$102.23$79.36$78.68$104.54
Market cap$86.6B$66.8B$36.9B$28.6B$28.7B$38.1B
P/E36.2×66.3×94.7×–157.4×209.4×
EV / revenue5.0×4.5×2.6×2.3×2.2×2.8×
EV / EBITDA22.6×31.9×23.0×749.4×20.6×26.6×
Price / free cash flow43.3×91.8×25.6×42.7×21.8×29.0×
Free-cash-flow yield2.3%1.1%3.9%2.3%4.6%3.5%
Price / book15.5×12.0×6.9×7.4×7.5×10.0×
Dividend yield0.98%1.39%2.58%2.15%1.78%1.34%

Fundamentals checklist ● 4 Good · ● 4 Average · ● 8 Bad · each check graded against the sector

Cash quality

Earnings backed by cash−8.1%Good
Free-cash-flow yield3.5%Bad

Risk models

Altman Z score2.8×Average
Piotroski F-Score6 of 9Average

Growth

EPS growth (3y)−43.6%Bad
Free-cash-flow growth (3y)21.8%Good
Revenue growth (3y)−1.8%Bad
Growth consistency60%Average

Balance sheet

Current ratio1.2×Good
Net debt / EBITDA3.6×Bad
Interest cover2.3×Bad

Valuation

Fair value vs price0.3×Bad
EBIT / EV yield1.8%Bad

Profitability

Return on invested capital5.7%Bad
Operating margin5.2%Average
Gross profitability57.5%Good
stocksxray.com · page 2
XStocksXray
Estee Lauder Companies Inc (EL)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statementFY22FY23FY24FY25FY26LTM
Revenue17,73715,91015,60814,32615,04915,049
Gross profit13,43211,34611,18410,59711,36211,362
Operating income3,1701,509970-785780780
Net income2,4081,010409-1,133182182
Diluted EPS ($)6.552.791.08-3.150.500.50
Free cash flow2,0007281,4416701,3161,316
Gross margin75.7%71.3%71.7%74.0%75.5%75.5%
Operating margin17.9%9.5%6.2%−5.5%5.2%5.2%
Net margin13.6%6.3%2.6%−7.9%1.2%1.2%
Balance sheetFY22FY23FY24FY25FY26LTM
Total assets20,91023,41521,67719,89219,76219,762
Cash3,9574,0293,3952,9213,4983,498
Total debt5,4129,1147,7717,3177,3067,306
Equity5,5905,5855,3143,8653,8063,806
Dividend per share ($)2.332.582.641.711.401.40

Revenue and net income US$ billions: navy revenue, teal net income

FY22FY23FY24FY25FY26

Margins blue gross, teal operating, brown net

-8%20%48%76%FY22FY23FY24FY25FY26

Latest quarters

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue ($M)3,5503,4113,4814,2293,7123,627
Growth vs a year earlier−9.9%−11.9%+3.6%+5.6%+4.6%+6.3%
Net income ($M)159-5464716289-116
Diluted EPS ($)0.44–0.130.440.24–
stocksxray.com · page 3
XStocksXray
Estee Lauder Companies Inc (EL)

Peers in Personal Care Products

CompanyX-Ray
EL · Estee Lauder Companies Inc33
PG · PROCTER & GAMBLE Co55
KVUE · Kenvue Inc.47

Market Compass outlook for Consumer Staples: Neutral (41/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week+6.6%
1 month+11.4%
3 months+25.4%
6 months+38.2%
1 year+11.3%
3 years−21.3%
5 years−63.8%

Technical summary

DailyStrongly bullish12 bullish · 3 neutral · 1 bearish
WeeklyStrongly bullish10 bullish · 1 neutral · 1 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish
50-day / 200-day average$96.48 / $91.19
52-week low / high$65.74 / $120.38
Classic pivot, support and resistanceS2 101.58 · S1 103.06 · P – · R1 107.37 · R2 110.20

Recent dividends

Ex-dividend dateAmount per share
31 Aug 2026$0.3500
29 May 2026$0.3500
27 Feb 2026$0.3500
28 Nov 2025$0.3500
2 Sep 2025$0.3500
30 May 2025$0.3500
stocksxray.com · page 4
XStocksXray
Estee Lauder Companies Inc (EL)

Strengths

  • Piotroski F-Score of 6 out of 9: most of the nine accounting health tests pass.

Risks and weak spots

  • Free-cash-flow yield is weak against Consumer Staples peers (3.5%).
  • EPS growth (3y) is weak against Consumer Staples peers (−43.6%).
  • Revenue growth (3y) is weak against Consumer Staples peers (−1.8%).
  • Net debt / EBITDA is weak against Consumer Staples peers (3.6×).
  • Interest cover is weak against Consumer Staples peers (2.3×).
  • Fair value vs price is weak against Consumer Staples peers (0.3×).
  • EBIT / EV yield is weak against Consumer Staples peers (1.8%).
  • Return on invested capital is weak against Consumer Staples peers (5.7%).

Latest SEC filings

DateFormItems
30 Sep 2026DEF 14A
8 Sep 20268-K7.01,9.01
19 Aug 202610-K
19 Aug 20268-K2.02,9.01
24 Jul 20268-K5.02,9.01
1 May 202610-Q
1 May 20268-K2.02,9.01
24 Mar 20268-K8.01,9.01

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.

stocksxray.com · page 5 · generated 19 Oct 2026